The Target of Metformin in Type 2 Diabetes

被引：95

作者：

Ferrannini, Ele ^{[1
]}

机构：

[1] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 16期

关键词：

D O I：

10.1056/NEJMcibr1409796

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1547 / 1548

页数：2

共 5 条

[1] Metformin and the intestine [J].

Bailey, C. J. ;

Wilcock, C. ;

Scarpello, J. H. B. .

DIABETOLOGIA, 2008, 51 (08) :1552-1553

[2] Drug therapy - Metformin [J].

Bailey, CJ ;

Turner, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579

[3] Secondary Failure of Metformin Monotherapy in Clinical Practice [J].

Brown, Jonathan B. ;

Conner, Christopher ;

Nichols, Gregory A. .

DIABETES CARE, 2010, 33 (03) :501-506

[4] Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase [J].

Madiraju, Anila K. ;

Erion, Derek M. ;

Rahimi, Yasmeen ;

Zhang, Xian-Man ;

Braddock, Demetrios T. ;

Albright, Ronald A. ;

Prigaro, Brett J. ;

Wood, John L. ;

Bhanot, Sanjay ;

MacDonald, Michael J. ;

Jurczak, Michael J. ;

Camporez, Joao-Paulo ;

Lee, Hui-Young ;

Cline, Gary W. ;

Samuel, Varman T. ;

Kibbey, Richard G. ;

Shulman, Gerald I. .

NATURE, 2014, 510 (7506) :542-+

[5] Vascular effects of improving metabolic control with melformin or rosiglitazone in type 2 diabetes [J].

Natali, A ;

Baldeweg, S ;

Toschi, E ;

Capaldo, B ;

Barbaro, D ;

Gastaldelli, A ;

Yudkin, JS ;

Ferrannini, E .

DIABETES CARE, 2004, 27 (06) :1349-1357

← 1 →